We are not able to resolve this OAI Identifier to the repository landing page. If you are the repository manager for this record, please head to the Dashboard and adjust the settings.
PhD thesisHepatocellular carcinoma (HCC) generally develops on the background of a chronic liver
disease following the accumulation of genetic damage and epigenetic alterations of growth
regulatory genes, leading to activation of oncogenes and loss of function of tumour
suppressor genes. Recent studies indicate that epigenetic aspects play an important role in
the initiation of HCC. This includes dysregulation of repeat elements belonging to the Long
Interspersed Nuclear Elements (LINE1 or L1) class. The L1 elements are autonomous mobile
elements and upon activation contribute towards genomic instability via insertional
mutagenesis. The thesis is aimed at understanding the factors leading to aberrant activation
of retrotransposons and regulators of active retrotransposition in the context of HCC. All the
liver cancer cell lines (Huh7, HepG2, Hep3B, PLC-PRF/5 and SK-Hep1) supported active
retrotransposition in vitro irrespective of their basal L1 expression status or TP53 status.
Since, active L1 retrotransposition through ‘Target Primed Reverse Transcription’ (TPRT)
involves first DNA strand nicking by ORF2 endonuclease followed by second strand cleavage,
we hypothesised that the DNA damage response pathways are involved in regulating the
process. To decipher the influence of individual DNA repair pathway elements on the process
of active retrotransposition, small molecule inhibitors towards ATM (KU-55933), DNA-PK (NU7441), ATR (VE-821), CHK1 (SRA737) and PARP (Rucaparib) were utilised. Overall, inhibition
of ATR (Ataxia Telangiectasia And Rad3-Related Protein), a serine/threonine kinase involved
in DNA replication stress and DNA damage signalling increased retrotransposition rate in all
the cell lines. In addition, an increase in active retrotransposition was observed in Huh7 cell
in presence of subgenomic copy of Hepatitis C Virus (HCV, a prevalent cause of HCC and
contributes towards hepatocarcinogenesis by inducing oxidative stress, DNA damage and
epigenetic changes in hepatocytes). Interestingly, the rate of retrotransposition remained
higher in cells compared to control cell lines even when they were treated with PSI7977
(antiviral agent) successfully eliminating the viral genome from the cells. Hence, HCV
upregulated active retrotransposition even beyond viral clearance and thus can contribute
towards hepatocarcinogenesis by a ‘hit-and-run’ mechanism. Interrogating publicly available
datasets - GSE84346 (RNAseq of Chronic HCV Hepatitis (CHC) patients and controls) and
RNAseq data of non-tumour liver from the Cancer Genome Atlas HCC study - confirmed
upregulation of L1 transcripts in chronic hepatitis patients liver. Hence, L1s can be activatedNewcastle University NUORS fellowship and JGW
Patterson special gran
Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.